Abstract:The overexpression of P-glycoprotein (Pgp), an ATP-driven membrane exporter of hydrophobic xenobiotics, is one of the major causes of multidrug resistance (MDR) in cancer cells. Through extensive screening we have found that the extracts of Peucedanum praeruptorum Dunn. and one of the major components (±)-praeruptorin A (PA) may reverse Pgp-mediated multidrug resistance. Studies on novel PA derivatives have shown that (±)-3′-O,4′-O-dicinnamoyl-cis-khellactone (DCK) is more active than PA or verapamil and is a non-competitive inhibitor of Pgp. Here, we report that methoxylation of the cinnamoyl groups on DCK may further enhance its bioactivity. The structure–activity relationship is demonstrated by comparing two new pyranocoumarins (±)-3′-O,4′-O-bis(3,4-dimethoxycinnamoyl)-cis-khellactone (DMDCK) and (±)-3′-O,4′-O-bis(4-methoxycinnamoyl)-cis-khellactone (MMDCK). While the co-existence of 3- and 4-methoxy groups on cinnamoyl remarkably enhanced the Pgp-inhibitory activity, the lone existence of the 4-methoxy group on cinnamoyl reduced the activity. Contrary to DCK, DMDCK promoted the binding of UIC2 antibody to Pgp which signifies a conformational change of Pgp similar to that induced by transport substrates. While DCK moderately stimulated the basal Pgp-ATPase activity, DMDCK inhibited the activity. A pharmacophore search with verapamil-based template revealed that four functional groups of DMDCK could be simultaneously involved in interaction with Pgp whereas for DCK or MMDCK only three groups were involved. It is speculated that the additional 3-methoxy group on cinnamoyl allows DMDCK to interact more efficiently with Pgp substrate site(s). If DMDCK was tightly bind to Pgp substrate site(s) the complexes could be inactive with regard to transportation and ATP hydrolysis could also be inhibited.

Synthesis of A Novel Series of (E,e)-4,6-bis(styryl)-2-o-glucopyranosyl-pyrimidines and Their Potent Multidrug Resistance (mdr) Reversal Activity Against Cancer Cells

Synthesis and Evaluation of Novel Podophyllotoxin Derivatives As Potential Antitumor Agents.

1-Benzyl-1,2,3,4-tetrahydroisoquinoline Derivatives and Optically Pure Isomers As Novel Promising Multidrug Resistance (mdr) Reversing Agents

Synthesis, Pharmacological Activity of a Series of Genistein Derivatives as Modulators of Multidrug Resistance

Synthesis of methylated quercetin derivatives and their reversal activities on P-gp- and BCRP-mediated multidrug resistance tumour cells.

Discovery of 5-Cyano-6-phenylpyrimidin Derivatives Containing an Acylurea Moiety As Orally Bioavailable Reversal Agents Against P-Glycoprotein-Mediated Mutidrug Resistance.

Synthesis and evaluation of novel tetrahydroisoquinoline-benzo[ h ]chromen-4-one conjugates as dual ABCB1/CYP1B1 inhibitors for overcoming MDR in cancer

Synthesis and Evaluation of Substituted Dibenzo[c,e]azepine-5-ones As P-glycoprotein-mediated Multidrug Resistance Reversal Agents

Seco-4-methyl-DCK Derivatives As Potent Chemosensitizers

Design, Synthesis and Biological Evaluation of Novel Triazole-Core Reversal Agents Against P-Glycoprotein-Mediated Multidrug Resistance

Synthesis and evaluation of stereoisomers of methylated catechin and epigallocatechin derivatives on modulating P-glycoprotein-mediated multidrug resistance in cancers

Design and Syntheses of Permethyl Ningalin B Analogues: Potent Multidrug Resistance (MDR) Reversal Agents of Cancer Cells

Synthesis and Antimultidrug Resistance Evaluation of Icariin and Its Derivatives

Synthesis and Primary Evaluation of Quinoxalinone Derivatives As Potent Modulators of Multidrug Resistance

Discovery to Solve Multidrug Resistance: Design, Synthesis, and Biological Evaluation of Novel Agents

Potent and Nontoxic Chemosensitizer of P-Glycoprotein-Mediated Multidrug Resistance in Cancer: Synthesis and Evaluation of Methylated Epigallocatechin, Gallocatechin, and Dihydromyricetin Derivatives.

Design, Synthesis and Antitumor Activity Evaluation Research of Novel 2,4,6-Substituted Pyrimidine Derivatives

Synthesis and Biological Evaluation of a Series of 6,7-Dimethoxy-1-(3,4- Dimethoxybenzyl)-2-substituted Tetrahydroisoquinoline Derivatives

Design, Synthesis and Biological Evaluation of LBM-A5 Derivatives As Potent P-glycoprotein-mediated Multidrug Resistance Inhibitors.

Exploring Pyrimidine-Substituted Curcumin Analogues: Design, Synthesis and Effects on Egfr Signaling

Methoxylation of 3',4'-aromatic side chains improves P-glycoprotein inhibitory and multidrug resistance reversal activities of 7,8-pyranocoumarin against cancer cells.